Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 84
Selected: 0
NCT IDTitle
NCT07113925A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies
NCT07400406A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance for the Detection of Calcified Coronary Arteries
NCT06172322A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer
NCT06764303A Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients
NCT06982040Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA Nephropathy
NCT05380882Clinical Trial of the TQB2930 Injection in Patients With Advanced Cancers
NCT06496490A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality
NCT06767800A Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma
NCT05045872Assessment of Renal Vasculature and Function with Ferumoxytol-enhanced Magnetic Resonance Imaging
NCT05450887Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis
NCT07043751A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors
NCT05409326A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult Subjects
NCT07653685A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the Treatment of Advanced Colorectal Cancer
NCT07745439A Drug-Drug Interaction Study Between NTQ5082 Capsules and Midazolam Oral Solutio
NCT06512363A Study of Ramelteon in Chinese Patients With Chronic Insomnia
NCT07177859A Phase III Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients
NCT05735496Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers
NCT05033587Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.
NCT05489276Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological Tumors
NCT06962267A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)
NCT06977763Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Injection
NCT07182552Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics of NTB003 in Healthy Participants
NCT06089278A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps.
NCT06825494Clinical Studies for the Treatment of Advanced Solid Tumors
NCT06049667A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies
NCT07003074A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer
NCT07052097Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis
NCT05494060XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
NCT06560593A Phase 1 Clinical Trial of NTQ5082 in Healthy Volunteers
NCT05493995A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer.
NCT06156280A Clinical Study of TQH2929 in Healthy Adult Subjects
NCT06219096Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection
NCT06700395A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma
NCT05867563Clinical Trial Evaluating the Safety of the TQB2103 for Injection
NCT05192512Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers
NCT06230588A Clinical Trial of TQH3906 Capsules in Healthy Volunteers
NCT01833923A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics
NCT07156643A Prospective, Single-arm, Multicenter Exploratory Clinical Study of Anlotinib Combined With Bempegaldesleukin and Conventional Chemoradiotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma.
NCT06672263A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia
NCT06106841TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
NCT06585059Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers
NCT06115902A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer
NCT06542614Treatment of Moderate to Severe Plaque Psoriasis
NCT05198505Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors
NCT02136992Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
NCT05262101Clinical Trial of TQB2858 Injection in the Treatment of Advanced High-grade Sarcoma
NCT06431490A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
NCT07044908TQB2922 and TAS-102 Tablets for Injection With or Without Bevacizumab in Chemotherapy-failed RAS/BRAF Wild-type Advanced Colorectal Cancer
NCT07393321A Phase III Clinical Trial of NTQ1062 in Combination With Fulvestrant for the Treatment of Advanced or Metastatic HR+/HER2- Breast Cancer
NCT06767813Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms